GT Biopharma (GTBP) had the highest return in 2012 by a US stock in the Nasdaq Composite (IXIC), returning 3,044,698,370%.
| ASSET | YEAR | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2012 | 3,044,698,370% |
INVO Fertility (IVF) | 2012 | 314,081.93% |
Versus Systems Inc. (VS) | 2012 | 163,639.24% |
Nixxy (NIXX) | 2012 | 64,900% |
Vivakor (VIVK) | 2012 | 1,224.46% |
Netcapital (NCPL) | 2012 | 600% |
Security National Financial (SNFCA) | 2012 | 487.2% |
Coda Octopus (CODA) | 2012 | 470.71% |
Sarepta Therapeutics (SRPT) | 2012 | 469.54% |
Consumer Portfolio Services (CPSS) | 2012 | 452.86% |
Imunon (IMNN) | 2012 | 376.16% |
BOS Better Online Solutions (BOSC) | 2012 | 355.56% |
BioLife Solutions (BLFS) | 2012 | 325% |
ACADIA Pharmaceuticals (ACAD) | 2012 | 322.73% |
Harrow Health (HROW) | 2012 | 306.25% |
Recon Technology (RCON) | 2012 | 305.8% |
Waterstone Financial (WSBF) | 2012 | 305.2% |
TOMI Environmental Solutions (TOMZ) | 2012 | 302.14% |
Sellas Life Sciences (SLS) | 2012 | 296.04% |
Patrick Industries (PATK) | 2012 | 276.75% |
Paysign (PAYS) | 2012 | 271.25% |
Lendingtree (TREE) | 2012 | 241.59% |
MiMedx (MDXG) | 2012 | 233.91% |
Helport AI Limited Ordinary Shares (HPAI) | 2012 | 233.33% |
Astrana Health (ASTH) | 2012 | 233.33% |
